Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5686423 | The Journal of Urology | 2017 | 37 Pages |
Abstract
Robot-assisted radical prostatectomy has comparable intermediate cancer control as evidenced by less use of additional postoperative cancer therapies and equivalent cancer specific and overall survival. Longer term followup is needed to assess for differences in prostate cancer specific survival, which was similar during intermediate followup. Our findings have significant quality and cost implications, and provide reassurance regarding the adoption of more expensive technology in the absence of randomized controlled trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jim C. Hu, Padraic O'Malley, Bilal Chughtai, Abby Isaacs, Jialin Mao, Jason D. Wright, Dawn Hershman, Art Sedrakyan,